Yiwu Ensheng Maternal and Infant Products Co., Ltd. – Trademark Portfolio
Entity Type: 99
Yiwu Ensheng Maternal and Infant Products Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include BAILIXIN. The owner is based in Yiwu, Zhejiang,.
1/Floor, No. 5, Building 18,
Duyuan Village, Houzhai Street,
Yiwu, Zhejiang, 322000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Yiwu Ensheng Maternal and Infant Products Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Yiwu Ensheng Maternal and Infant Products Co., Ltd. have?
Yiwu Ensheng Maternal and Infant Products Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Yiwu Ensheng Maternal and Infant Products Co., Ltd. file in?
Yiwu Ensheng Maternal and Infant Products Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Yiwu Ensheng Maternal and Infant Products Co., Ltd.'s most well-known trademarks?
Yiwu Ensheng Maternal and Infant Products Co., Ltd.'s registered trademark portfolio includes well-known marks such as BAILIXIN. These are among 1 currently registered trademark in the portfolio.
What is Yiwu Ensheng Maternal and Infant Products Co., Ltd.'s trademark registration success rate?
Yiwu Ensheng Maternal and Infant Products Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.